Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens
Clinical trial NCT01406938 · COMPLETED
Trial details
- NCT number
- NCT01406938
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2013-05-01
- Enrollment
- 967
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.